CervoMed Inc. Files 8-K
Ticker: CRVO · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, company-information
TL;DR
CervoMed (CRVO) filed an 8-K on 3/10/25. Nothing major disclosed yet.
AI Summary
CervoMed Inc. filed an 8-K on March 10, 2025, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This filing provides an update on CervoMed Inc.'s corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing that primarily provides corporate information and does not appear to contain significant new material events or financial disclosures.
Key Numbers
- 001-37942 — SEC File Number (Identifies the company's filing with the SEC)
- 30-0645032 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- RestorGenex Corp (company) — Former company name
- Stratus Media Group, Inc (company) — Former company name
- 20250310 (date) — Filing date
FAQ
What specific 'Other Events' are being reported by CervoMed Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item of information, but the specific details of these events are not provided in the excerpt.
When was CervoMed Inc. previously known as Diffusion Pharmaceuticals Inc.?
The date of name change from Diffusion Pharmaceuticals Inc. to CervoMed Inc. is not explicitly stated, but the filing lists it as a former company.
What is the principal executive office address for CervoMed Inc.?
The principal executive offices are located at 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
What is the Standard Industrial Classification (SIC) code for CervoMed Inc.?
The SIC code for CervoMed Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for CervoMed Inc.?
The fiscal year end for CervoMed Inc. is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding CervoMed Inc. (CRVO).